Page last updated: 2024-08-23

staurosporine and Acinar Carcinoma

staurosporine has been researched along with Acinar Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brandt-Rauf, PW; Chie, L; Chung, DL; Kanovsky, M; Michl, J; Pincus, MR; Sivendran, S; Smith, S; Way, D	1

Other Studies

1 other study(ies) available for staurosporine and Acinar Carcinoma

Article	Year
A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti- ras peptide. Cancer chemotherapy and pharmacology, 2002, Volume: 49, Issue:6 Topics: Antineoplastic Agents; Carcinoma, Acinar Cell; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Oncogene Protein p21(ras); Pancreatic Neoplasms; Peptide Fragments; Phenotype; Protein Binding; Protein Kinase C; Signal Transduction; Staurosporine	2002

Article

Year

A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti- ras peptide.

Cancer chemotherapy and pharmacology, 2002, Volume: 49, Issue:6

Topics: Antineoplastic Agents; Carcinoma, Acinar Cell; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Oncogene Protein p21(ras); Pancreatic Neoplasms; Peptide Fragments; Phenotype; Protein Binding; Protein Kinase C; Signal Transduction; Staurosporine

2002